Company profile: Longeviti Neuro Solutions
1.1 - Company Overview
Company description
- Provider of implantable neurosurgical devices, developing and commercializing these products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Longeviti Neuro Solutions
Cingulate
HQ: United States
Website
- Description: Provider of precision timed-release therapeutics combining delivery technology with proven medications to deliver rapid-onset, once-daily, full-day efficacy. Portfolio includes ADHD treatments CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), and CTx-2103 (buspirone HCl) for anxiety under development, powered by its Precision Timed Release (PTR) platform enabling predefined release times.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cingulate company profile →
Cara Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapeutics targeting pain and inflammation, including KORSUVA (difelikefalin), an FDA-approved treatment for moderate to severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis, and research and development focused on treating pruritus in Notalgia Paresthetica.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cara Therapeutics company profile →
Anaconda Biomed
HQ: Spain
Website
- Description: Provider of next-generation catheter-based medical devices for efficient mechanical thrombectomy, developing the ANCD BRAIN, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anaconda Biomed company profile →
Alpha Cognition
HQ: Canada
Website
- Description: Provider of therapies for underserved neurodegenerative diseases, including ALPHA-1062, a prodrug AChEI for mild-to-moderate Alzheimer's aiming to reduce gastrointestinal side effects; ALPHA-1062 + memantine for moderate-to-severe Alzheimer's; intranasal ALPHA-1062 for cognitive impairment in mTBI; ALPHA-0602 gene therapy delivering progranulin for ALS; and progranulin-derived GEM candidates ALPHA-0702 and ALPHA-0802.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alpha Cognition company profile →
VistaGen Therapeutics
HQ: United States
Website
- Description: Provider of investigational biopharmaceutical therapies for CNS diseases and disorders: Fasedienol (for multiple anxiety disorders), Itruvone (for major depressive disorder and other depression-related conditions), PH80 (menopausal hot flashes, premenstrual dysphoric disorder, migraines), PH15 (to improve cognition), PH284 (appetite-related disorders, including Cachexia), AV-101 (oral prodrug targeting the NMDA receptor glycine site).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VistaGen Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Longeviti Neuro Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Longeviti Neuro Solutions
2.2 - Growth funds investing in similar companies to Longeviti Neuro Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Longeviti Neuro Solutions
4.2 - Public trading comparable groups for Longeviti Neuro Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →